NSLI
PFE icon

Nan Shan Life Insurance’s Pfizer PFE Stock Holding History

Nan Shan Life Insurance’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$79.6M Buy
3,306,108
+235,799
+8% +$6.17M 2.49% 11
2026
Q1 		$86.2M Buy
3,070,309
+1,301,657
+74% +$34.7M 3.12% 9
2025
Q4 		$44M Hold
1,768,652
– – 1.35% 22
2025
Q3 		$45.1M Hold
1,768,652
– – 0.96% 30
2025
Q2 		$42.9M Hold
1,768,652
– – 0.95% 32
2025
Q1 		$44.8M Hold
1,768,652
– – 1.06% 24
2024
Q4 		$46.9M Hold
1,768,652
– – 1.13% 29
2024
Q3 		$51.2M Buy
1,768,652
+849,971
+93% +$24.8M 1.21% 24
2024
Q2 		$25.7M Buy
+918,681
New +$25.3M 0.61% 60

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Nan Shan Life Insurance's PFE Position: Q2 2026 in Review

Nan Shan Life Insurance increased its Pfizer (PFE) stake by 7.7% in Q2 2026, buying an estimated $6.17M and bringing the position to 3,306,108 shares worth $79.6M. The position accounts for 2.49% of the portfolio, ranked #11.

Nan Shan Life Insurance first reported a position in PFE in Q2 2024 and has held it in 9 quarters since. The position peaked at $86.2M in Q1 2026. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Nan Shan Life Insurance held 3,306,108 shares of Pfizer worth $79.6M as of Q2 2026.
  • Nan Shan Life Insurance bought 235,799 Pfizer shares in Q2 2026, an estimated $6.17M.
  • Pfizer made up 2.49% of Nan Shan Life Insurance's portfolio in Q2 2026, its #11 holding.
  • Nan Shan Life Insurance first reported a position in Pfizer in Q2 2024 and has held it in 9 quarters since.
  • Nan Shan Life Insurance's Pfizer position peaked at $86.2M in Q1 2026.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Nan Shan Life Insurance's 13F filing for Q2 2026, filed 14 Aug 2026.